Usana Health Sciences Inc logo

USNA

Usana Health Sciences Inc

$72.32

Earnings Summary

Revenue
$264.47Mn
Net Profits
$19.16Mn
Net Profit Margins
7.24%
PE Ratio
13.25

Highlights

Revenue:

Usana Health Sciences Inc’s revenue fell -21.48% since last year same period to $264.47Mn in the Q2 2022. On a quarterly growth basis, Usana Health Sciences Inc has generated -3.08% fall in its revenue since last 3-months.

Net Profits:

Usana Health Sciences Inc’s net profit fell -49.9% since last year same period to $19.16Mn in the Q2 2022. On a quarterly growth basis, Usana Health Sciences Inc has generated -14.74% fall in its net profits since last 3-months.

Net Profit Margins:

Usana Health Sciences Inc’s net profit margin fell -36.19% since last year same period to 7.24% in the Q2 2022. On a quarterly growth basis, Usana Health Sciences Inc has generated -12.03% fall in its net profit margins since last 3-months.

PE Ratio:

Usana Health Sciences Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 13.25.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Usana Health Sciences Inc post its latest quarter earnings

EPS Estimate Current Quarter
1.09
EPS Estimate Current Year
1.09

Highlights

EPS Estimate Current Quarter:

Usana Health Sciences Inc’s earning per share (EPS) estimates for the current quarter stand at 1.09 - a -4.39% fall from last quarter’s estimates.

EPS Estimate Current Year:

Usana Health Sciences Inc’s earning per share (EPS) estimates for the current year stand at 1.09.

Key Ratios

Key ratios of the Usana Health Sciences Inc post its Q2 2022 earnings

Earning Per Share (EPS)
1
Return on Assets (ROA)
0.17
Return on Equity (ROE)
0.28
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Usana Health Sciences Inc’s earning per share (EPS) fell -46.52% since last year same period to 1 in the Q2 2022. This indicates that the Usana Health Sciences Inc has generated -46.52% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Usana Health Sciences Inc’s return on assets (ROA) stands at 0.17.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Usana Health Sciences Inc’s return on equity (ROE) stands at 0.28.

Dividend Per Share (DPS):

Usana Health Sciences Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-06-30
1.14
1
-12.28%
2022-05-11
1.14
1.15
0.88%

Company Information

USANA prides itself in providing consumers the highest quality nutritional products in the world. From its award-winning supplements to its innovative skincare line, USANA has proven for more than 25 years why it's a company wworth of trust.

Organisation
Usana Health Sciences Inc
Headquarters
Salt Lake City, Utah, United States
Employees
1.94K
Industry
Consumer Non-Durables
CEO
Kevin Guest